David C. Muller

Also affiliated with Imperial College London

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program”.

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Annals of Epidemiology(2022)10.1016/j.annepidem.2022.10.014

N/A

0.524DataRank · unranked

32 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +51 more

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

European Heart Journal(2021)10.1093/eurheartj/ehab309

N/A

0DataRank · unranked

1682 citations

Lisa Pennells, Francisco Ojeda, Stephen Kaptoge, Kari Kuulasmaa, Tamar I. de Vries +95 more

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma

Human Molecular Genetics(2021)10.1093/hmg/ddab031

N/A

0DataRank · unranked

41 citations

Peng Li, Szilvia Ecsedi, Behnoush Abedi‐Ardekani, Geoffroy Durand, Nivonirina Robinot +20 more

Phosphorylation of the MNK1 substrate eIF4E is not required for response to acute pancreatitis

Pancreatology(2021)10.1016/j.pan.2021.02.013

N/A

0DataRank · unranked

3 citations

Manon Strehaïano, David C. Muller, Charline Lasfargues, Stéphanie Cassant‐Sourdy, Christine Jean +4 more

Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac061

N/A

0DataRank · unranked

30 citations

Karl Smith-Byrne, Tom G. Richardson, Pietro Ferrari, Marc J. Gunter, Nikos Papadimitriou +31 more

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

medRxiv(2022)10.1101/2022.03.21.22272544

N/A

0DataRank · unranked

3 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +50 more

The blood proteome of imminent lung cancer diagnosis

Nature Communications(2023)10.1038/s41467-023-37979-8

N/A

0DataRank · unranked

79 citations

Karine Alcala, Nicolas Alcala, Christopher I. Amos, Alan A. Arslan, Julie K. Bassett +33 more

Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad071

N/A

0DataRank · unranked

23 citations

Wendy Wu, Justina Ucheojor Onwuka, Z. Haider, Karine Alcala, Karl Smith‐Byrne +33 more

Protein-altering germline mutations implicate novel genes related to lung cancer development

Nature Communications(2020)10.1038/s41467-020-15905-6

N/A

0DataRank · unranked

49 citations

Semanti Mukherjee, Maria Teresa Landi, Yohan Bossé, Philippe Joubert, Dakai Zhu +95 more

Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis

EBioMedicine(2023)10.1016/j.ebiom.2023.104623

N/A

0DataRank · unranked

3 citations

David C. Muller, Hana Zahed, Karine Alcala, Florence Guida, Karl Smith-Byrne +16 more